Question 1

What is Angel Pharmaceuticals?

Accepted Answer

Angel Pharmaceuticals is a Entity.

Question 2

How often does Angel Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Angel Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on May 07, 2026.

Question 4

When was Angel Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on May 14, 2026.

Question 5

What is Angel Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Angel Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Angel Pharmaceuticals?

Accepted Answer

Corvus Soquelitinib Phase 1 Atopic Dermatitis Data (May 07, 2026, 7 articles).

Question 8

How did the "Corvus Soquelitinib Phase 1 Atopic Dermatitis Data" event impact Angel Pharmaceuticals?

Accepted Answer

Angel Pharmaceuticals, Corvus Pharmaceuticals' partner in China, is also enrolling patients in a Phase 1b/2 clinical trial for Soquelitinib in atopic dermatitis, indicating broader development and market potential for the drug.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.